Surterra Texas™ Launches First Medical Cannabis Lotions for the Texas Compassionate Use Program – PRNewswire

Surterra Texas’ lotions are being introduced in two product lines:  Tranquil™ Lotion with a 19:1 ratio of CBD:THC (342mg CBD and 18mg THC per package) and Soothe™ Lotion with a 1:1 ratio of CBD:THC (180mg CBD and 180mg THC per package). Each child-resistant jar of lotion will be available for $60.

“We are excited to be, once again, the first to bring a new cannabis product category to our patients in the state of Texas. Regardless of if a patient wants to treat a specific area with our new lotions or get full body relief from our lozenges, we’re committed to providing a variety of formats to help customers unlock the benefits of cannabis,” said Marcus Ruark, President of Surterra Texas. “Surterra Texas continues to lead the Texas Compassionate Use Program in product innovation and providing Texans with the widest variety of medical cannabis products.”

In addition to offering the first medical cannabis lotions, Surterra Texas continues to offer Texas’ only THC-dominant product, the Relief™ Lozenges with a 1:9 CBD:THC ratio, as well as a variety of medical cannabis tinctures with a range of ratios and targeted terpene profiles.  Each Surterra Wellness product has been formulated with specific cannabinoid ratios to help patients with approved treatable conditions under the Texas Compassionate Use Program, including terminal cancer, spasticity, autism, multiple sclerosis, epilepsy, and a wide range of neurological diseases.

Patients interested in learning more about Surterra Texas products—or to find out how to consult with board-certified physicians for a medical cannabis prescription—should begin by visiting  Surterra Texas offers convenient contactless delivery of its products across the state of Texas, including Houston, Dallas-Fort Worth, San Antonio, and Austin, as well as discounts for first-time patients and members of military families.

Surterra Wellness, widely known for its line of tinctures,

Read More Here...

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top